Benjamin Guy Davis
Direktor/Vorstandsmitglied bei Sugarox Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Peagram | M | 81 |
Sugarox Ltd.
 Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
| Bianca Forte | F | 44 |
Sugarox Ltd.
Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
| Cara Ashleigh Griffiths | M | - |
Sugarox Ltd.
Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
| Matthew Jeremy Paul | M | 61 |
Sugarox Ltd.
Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | 3 Jahre |
| Angela Karp | F | 67 |
Sugarox Ltd.
Sugarox Ltd. Miscellaneous Commercial ServicesCommercial Services Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR). | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Landon Clay | M | 98 |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| Elizabeth Phelps | F | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| Mario Polywka | M | 61 |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 7 Jahre |
| Gavin David Clark | M | 65 |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 3 Jahre |
| Louis Joseph Nisbet | M | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| Chris Urch | M | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 7 Jahre |
| Antony J. Fairbanks | M | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 9 Jahre |
| James Mallinson | M | 63 |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| David Hughes Scales | M | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 3 Jahre |
| Phillip Dolamore | M | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | - |
| Niels Reichardt | M | - |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 16 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Benjamin Guy Davis
- Persönliches Netzwerk
